CLBT
Cellebrite DI
11.10$
-0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.3% | 16.0% | 14.8% | 17.0% | 14.5% | 16.2% | 16.3% | 15.6% | 16.1% | 15.3% | 17.5% | 19.2% | 17.0% | |
| 84.7% | 84.0% | 85.2% | 83.0% | 85.5% | 83.8% | 83.7% | 84.4% | 83.9% | 84.7% | 82.5% | 80.8% | 83.0% | |
| 24.3% | 23.4% | 25.9% | 24.8% | 24.3% | 23.5% | 25.4% | 25.3% | 22.3% | 23.2% | 28.0% | 27.4% | 25.2% | |
| 12.5% | 12.6% | 13.2% | 11.4% | 12.7% | 13.4% | 10.9% | 12.3% | 15.7% | 15.4% | 13.8% | 48.1% | 23.4% | |
| 68.7% | 67.8% | 74.9% | 70.0% | 67.4% | 69.4% | 72.3% | 71.7% | 68.8% | 68.6% | 75.4% | 75.0% | 72.0% | |
| 16.0% | 16.1% | 10.3% | 13.0% | 18.2% | 14.4% | 11.4% | 12.7% | 15.1% | 16.2% | 7.1% | 5.8% | 11.0% | |
| 7.9% | 29.4% | 87.7% | 36.0% | 209.6% | 1.2% | – | – | – | – | – | – | – | |
| 8.1% | -13.3% | -77.4% | -23.0% | -191.4% | 18.2% | 18.0% | 18.4% | 19.3% | 20.4% | 10.6% | 8.5% | 14.7% | |
| 0.4% | 2.5% | 2.3% | 1.9% | 2.4% | 0.6% | 1.8% | 1.2% | 3.3% | 3.9% | 2.1% | 3.7% | 3.2% | |
| 7.7% | -15.7% | -79.7% | -24.9% | -193.8% | 17.7% | 16.2% | 17.2% | 16.0% | 16.5% | 8.5% | 4.9% | 11.4% | |
| 18.8% | -97.9% | 13.3% | 15.7% | 20.7% | -288.3% | 20.4% | 26.9% | 21.4% | 38.4% | 16.1% | 12.6% | 22.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.